Free exopolysaccharide from Mycoplasma mycoides subsp. mycoides possesses anti-inflammatory properties
© Totté et al. 2015
Received: 3 February 2015
Accepted: 28 August 2015
Published: 21 October 2015
In this study we explored the immunomodulatory properties of highly purified free galactan, the soluble exopolysaccharide secreted by Mycoplasma mycoides subsp. mycoides (Mmm). Galactan was shown to bind to TLR2 but not TLR4 using HEK293 reporter cells and to induce the production of the anti-inflammatory cytokine IL-10 in bovine macrophages, whereas low IL-12p40 and no TNF-α, both pro-inflammatory cytokines, were induced in these cells. In addition, pre-treatment of macrophages with galactan substantially reduced lipopolysaccharide (LPS)-induced production of pro-inflammatory cytokines TNF- and IL-12p40 while increasing LPS-induced secretion of immunosuppressive IL-10. Also, galactan did not activate naïve lymphocytes and induced only low production of the Th1 cytokine IFN-γ in Mmm-experienced lymphocytes. Finally, galactan triggered weak recall proliferation of CD4+ T lymphocytes from contagious bovine pleuropneumonia-infected animals despite having a positive effect on the expression of co-stimulatory molecules on macrophages. All together, these results suggest that galactan possesses anti-inflammatory properties and potentially provides Mmm with a mechanism to evade host innate and adaptive cell-mediated immune responses.
Contagious bovine pleuropneumonia (CBPP) is a contagious respiratory disease caused by Mycoplasma mycoides subsp. mycoides small colony biotype (Mmm) and notifiable to the World Organization for Animal Health . Respiratory distress occurs in acute forms of CBPP frequently followed by death in the absence of antibiotic treatment. Lesions in the thoracic cavity are suggestive of an overwhelming inflammatory response developed by the host. The prominent lesions in the lung include: thrombosis of lymphatics and blood vessels; interlobular edema; hepatisation and consolidation of individual lobules leading to a marbled appearance of the lung, and yellow or turbid exudates in the pleural cavity (reviewed in ). In addition, archetypal inflammatory cytokines are detected in vitro in supernatants of macrophages stimulated with several Mmm strains and in vivo in the plasma of cattle during the course of experimental infection with virulent Mmm [3, 4].
The mechanisms and components of Mmm involved in immunomodulation in general and in host inflammatory responses in particular are poorly characterized. Available Mmm sequenced genomes [5, 6] indicate that classical virulence determinants such as toxins, invasins or cytolysins, are absent in Mmm. More probably, the virulence factors of mycoplasma species seem to be determined by intrinsic metabolic pathway functions [7, 8] or by constituents of the mycoplasmal outer surface including lipoproteins and polysaccharides. Mmm cells secrete galactan, a homopolysaccharide consisting of β1 → 6 galactofuranosyl sub-units and present as a capsular form (CPS) and as a free extracellular form hereafter termed exopolysaccharide (EPS) [9, 10]. While CPS and EPS possess the same type of homopolysaccharide, the former differs from the latter as it is linked to a lipid anchored moiety, probably a diglycosyldiacylglycerol residue as for Mycoplasma genitalium . The physical and biological properties of CPS and EPS may therefore vary considerably. Galactan EPS is secreted in high quantities by Mmm that multiply in the lung lesions and, because it is soluble, it is found in large amounts in the blood of infected cattle . Biological effects of crude galactan observed after intravenous injection in cattle include: increased pulmonary arterial and decreased systemic arterial blood pressures, hemorrhages associated with alveolar ducts and vessel walls, areas of pulmonary edema, induced lesions in joints and kidneys and a prolonged mycoplasmaemia after subcutaneous injection of live Mmm [13, 14]. These results suggest a possible role for galactan as a pro-inflammatory factor although the contribution of contaminating components such as polypeptides and non-Mmm polysaccharides present in the enriched culture medium cannot be excluded. Recently, we reported a method using a chemically defined synthetic medium to maintain Mmm viability and allow the preparation of free galactan EPS of high purity as shown by silver staining on SDS-PAGE and nuclear magnetic resonance spectroscopy .
Macrophages express a large repertoire of pathogen-recognition receptors, including toll-like receptors (TLRs), and are key players in the initiation of inflammatory responses during infection . Inflammation is a highly complex response under the control of a network of cytokines with either pro-inflammatory effects such as IL-1β, IL-12p40, TNF-α, IFN-γ, or anti-inflammatory properties such as IL-10 and TGF-β (reviewed in ). Bacterial polysaccharides are capable of inducing the production of pro-inflammatory cytokines by macrophages through interaction with TLR2 and/or TLR4 [17–21]. In addition, lymphocytes of the Th1 subset may also trigger or exacerbate inflammation as a result of interactions with bacterial polysaccharides through a mechanism depending on both TLR2 and antigen presentation [18, 22]. Importantly, antigen presentation to lymphocytes by antigen presenting cells (APC) such as dendritic cells and macrophages requires expression of co-stimulatory molecules including CD40, CD80, and CD86 .
In an effort to address the pathogenesis of CBPP, we investigated the interactions of highly purified galactan EPS, the free exopolysaccharide of Mmm, with bovine cells involved in both innate and acquired immunity. First of all, binding of galactan to TLRs was analyzed using highly sensitive transformed cell lines. Then, the effects of galactan on cytokines production and expression of co-stimulatory molecules by bovine macrophages were characterized. Finally, the capacity of galactan to trigger a pro-inflammatory Th1-like response from lymphocytes of naïve and CBPP-infected animals was investigated.
Materials and methods
The use of cattle as a source of macrophages and lymphocytes was approved by the Languedoc-Roussillon Animal Ethics Committee (CEEA-LR No. 36) and carried out in strict accordance with the French Ministry of Agriculture’s guidelines for use of animals for scientific purposes.
Preparation of galactan and whole antigen from Mmm
Mmm strains Afadé and T1/44 were used for galactan purification and stimulation of lymphocytes respectively. For the preparation of highly pure galactan EPS, Mmm Afadé was first grown in PPLO-based medium before transfer in chemically defined CMRL-1066 medium (Invitrogen, France) in which de novo synthesis of polysaccharides was previously shown . To purify the galactan EPS, cells were removed by centrifugation and polypeptides were precipitated from the supernatant with 1/10 volume of cold 100% (w/v) trichloroacetic acid (Sigma-Aldrich) at 4 °C for 2 h followed by centrifugation (14 000 g, 60 min, 4 °C). Polysaccharides contained in the supernatant were precipitated with 6–10 volumes of cold acetone at −20 °C for 48 h and collected after centrifugation (14 000 g, 60 min, 4 °C). The acetone was carefully removed and the pellet was air-dried and dissolved in ultra-pure sterile water and dialyzed in 3.5 kDa cut-off dialysis tubing (Spectrum Laboratories) to remove small peptides. Galactan concentration was estimated by the phenol/sulfuric acid method using glucose as standard and stored at 4 °C until used .
Killed Mmm were also prepared from log phase T1/44 cultures grown in PPLO and washed two times in PBS before protein titration by the bicinchoninic acid method. The T1/44 strain of Mmm was chosen as a positive control of antigen-specific proliferation as shown in previous work . Mmm organisms had to be inactivated before use in co-cultures with lymphocytes to avoid direct killing of cells . Whole inactivated Mmm antigen was obtained after heating at 60 °C for 1 h and was stored at −20 °C until used.
Macrophages and cell lines expressing TLRs
For macrophages, heparinized blood was collected from the jugular vein of healthy cattle and peripheral blood mononuclear cells (PBMC) were purified using standard procedures. Monocytes were separated from other cells by positive selection of CD14+ cells using anti-human CD14 magnetic microbeads (Miltenyi Biotec GmbH, Germany) according to the manufacturer’s instructions and resuspended in Iscove’s modified Dulbecco’s medium (IMDM) supplemented with 2 mM l-glutamine, 50 μM 2-mercaptoethanol, 50 µg/mL gentamycin (Life Technologies, France) and 10% heat inactivated fetal calf serum (FCS; Eurobio AbCys, France). CD14+ cells were seeded at 1 × 106 cells/mL in 24-well plates and incubated for 5 days at 37 °C and 5% CO2. For stimulation assays, macrophages were incubated for 48 h at 37 °C and 5% CO2 with different concentrations of galactan or 2 μg/mL of lipopolysaccharide (LPS) from Escherichia coli 0111:B4 (Invivogen, France) as a positive control. Supernatants were centrifuged at 300 × g to remove cells before storage at −20 °C.
HEK-Blue™ mTLR2 (HEK-TLR2) and HEK-Blue™ mTLR4 (HEK-TLR4) cell lines (Invivogen, France) are derivative of HEK293 cells obtained respectively by co-transfection of the mouse TLR2 or TLR4 and secreted embryonic alkaline phosphatase (SEAP) genes. Ligand activation of TLR induces production of SEAP and QUANTI-Blue™ (Invivogen, France), a colorimetric enzyme assay, allows quantification of SEAP in supernatants using a spectrophotometer at 620-655 nm. HEK-Blue™ Null1 (HEK-Null1) and HEK-Blue™ Null2 (HEK-Null2) cell lines (Invivogen, France) are parental cell lines transfected only with the SEAP gene. For stimulation assays, cells were seeded in 96-wells plates in recommended media (Invivogen, France) and incubated for 20 h at 37 °C and 5% CO2 with different concentrations of EPS, and with specific TLR agonists (Invivogen, France): 100 ng/mL of synthetic diacylated lipoprotein (FSL1) for TLR2, and 10 ng/mL of LPS from E. coli 0111:B4 for TLR4. Supernatants were titrated for alkaline phosphatase activity in duplicates.
Cells were prepared from mediastinal lymph nodes draining the lungs of naïve and CBPP-infected cattle (also called Mmm-experienced cells) and stored in liquid nitrogen as previously described . Upon thawing, cells were loaded with carboxyfluorescein diacetate succinimidyl ester (CFSE, Invitrogen, France) at a final concentration of 1 μM before incubation for 7 days with 5 μg/mL of heat-inactivated Mmm or 2.5 μg/mL of the mitogen Concanavalin A (ConA) as a positive control. Cells from CBPP-infected and naïve animals showed similar reactivity to ConA and only assays in which ConA controls were within an acceptable range were analyzed further. Galactan was used at a final concentration of 10 μg/mL unless specified otherwise. Finally, purified protein derivative from Mycobacterium avium subsp. paratuberculosis (PPDa) cultures (Prionics AG, Switzerland) was used as irrelevant antigen to measure non-specific proliferation.
Lymph node cells were surface stained with the following primary monoclonal antibodies (mAb): mAb IL-A11 (IgG2a) for CD4 (VMRD, USA). Macrophages were stained with mAb IL-A156 for CD40, and mAb IL-A159 for CD80 (all IgG1 isotype from AbD Serotec, UK). Cells were then washed and stained with fluorochrome-conjugated, isotype-specific antibodies. Debris and dead cells were excluded from analysis based on granularity and size and, for lymphocytes, based on inclusion of 7-amino-actinomycin D (7-AAD) as a viability dye (BD Biosciences, USA). Multiple color analyses were performed with a flow cytometer (FACScanto; Becton–Dickinson) equipped with the FACSDiva software (BD Biosciences) after the acquisition of at least 5000 events. Control isotype antibodies (AbD Serotec, UK) were used to evaluate nonspecific binding and to set gates and quadrants delineating positive populations. Results were expressed as percentages of positively labeled cells and/or geometric mean fluorescence intensity (MFI). Proliferation levels were expressed as percentages of CFSElow cells which correspond to decreased CFSE fluorescence intensity relative to that in undivided cells.
For bovine IFN-γ, the Bovigam™ ELISA kit (Prionics AG, Switzerland) was used according to the manufacturer’s instructions and results are expressed as mean optical densities of duplicate assays. For bovine IL-10, IL-12p40, and TNF-α, matched antibody pairs (AbD Serotec, UK) were used in sandwich ELISA as described previously  with minor modifications. Briefly, 96 wells NUNC MaxiSorp™ plates (Thermo Fisher Scientific, Germany) were coated with capture antibodies and washed after blocking. After incubating the plates with culture supernatants in duplicates, and washing, specific detection antibodies coupled to biotin were added. Serial dilutions of recombinant bovine cytokines were used to generate a calibration curve. After washing, the plates were incubated with streptavidin coupled to horseradish peroxidase (Sigma-Aldrich, France) and washed before adding a solution containing tetramethylbenzidine (TMB). The reaction was blocked with H2SO4 at 1 M and plates were read at 450 nm using an ELISA reader. Results are expressed as mean protein concentrations.
A nonparametric Mann–Whitney U-test  was used to analyze differences between responses obtained with various stimuli. A difference was considered to be significant at a p value of <0.05.
Galactan is recognized by TLR2 but not TLR4
Galactan induces an anti-inflammatory cytokine response in bovine macrophages and inhibits the pro-inflammatory activity of LPS
Cell-surface expression of co-stimulatory molecules on bovine macrophages is increased by galactan
CD4+ T cells from CBPP-infected cattle but not naïve animals proliferate in response to galactan and produce low levels of IFN-γ
The Mmm polysaccharide, galactan, is highly immunogenic as shown by antibody responses detected during infection and characterized by a very rapid and high level of IgM directed towards polysaccharidic Mmm components . However, at the same time, Mmm that multiply in lung lesions are secreting free galactan EPS but there is no data available concerning the immunomodulatory properties of this compound. In this study, we investigated the impact of EPS on innate immunity through activation of bovine macrophages and naïve lymphocytes, and, on adaptive immunity, through expression of co-stimulatory molecules on macrophages and recall activation of Mmm-experienced lymphocytes.
The first step of this study was to identify a receptor for galactan among TLRs given their essential role in the early recognition of bacterial infections by the host immune system. Galactan was shown to interact with TLR2 which was supporting evidence for a potential involvement in innate immunity through interaction with TLR2-expressing cells such as macrophages and T lymphocytes . The high purity grade of the galactan preparation used in our study was shown previously by silver staining on SDS-PAGE and nuclear magnetic resonance spectroscopy (NMR) . However, as reported by Geurtsen et al.  for α-glucan purified from Mycobacterium tuberculosis, lipopeptides can be present at concentrations not detectable even by NMR and still induce substantial TLR2-dependent activity. In addition, the authors showed that these lipopeptides were successfully removed by phenol treatment . In our model, we observed that reporter HEK cells could easily detect TLR2 activity triggered by FSL1, a lipopeptide produced by Mycoplasma salivarium, even at concentrations as low as 100 pg/mL (Additional file 3B). Therefore, we tested phenol treatment and showed that it did not significantly affect the TLR2 activity of galactan whereas it completely abrogated the activity of FSL1 (Additional file 3).
In contrast to TLR2-expressing HEK cells, we could not detect any activation of naïve lymphocytes by galactan as shown by the absence of cytokine release, proliferation, or even morphological changes (i.e., blastogenesis and cell death). Also, galactan had no measurable effects on naïve CD4+ T lymphocytes and this was not due to cytotoxicity. On the other hand, interaction between galactan and bovine macrophages resulted in a substantial release of IL-10, whereas low IL-12p40 and no TNF-α, both pro-inflammatory cytokines, were induced in these cells. In addition, the anti-inflammatory activity of galactan was confirmed by its ability to counteract the activity of LPS, a potent mediator of inflammation. Indeed, pre-treatment of macrophages by galactan dramatically reduced TNF-α and IL-12p40 responses triggered by LPS but also significantly increased (i.e., up to 300%) the production of IL-10. The lack of pro-inflammatory activity of certain polysaccharides and their capacity to inhibit LPS pro-inflammatory activity has been reported previously [30–34] and notably for another mycoplasmal EPS . Moreover, α-glucan from Mycobacterium tuberculosis is known to amplify the LPS-mediated production of IL-10 by dendritic cells . However, a dual effect, as described here for Mmm galactan and consisting in the concomitant inhibition of LPS pro-inflammatory activity and amplification of LPS anti-inflammatory activity via IL-10, has not been reported for other polysaccharides to the best of our knowledge. The galactan-mediated reduction of LPS-induced TNF-α release by macrophages may be explained by IL-10 acting on transcription factors such as STAT3 . On the other hand, the amplification effect of galactan on LPS-induced IL-10 is probably more complex. For example, certain lipoglycans and glycans from Mycobacterium tuberculosis induce both prolonged and increased IL10 transcription in LPS-activated cells through interaction with C-type lectins rather than TLRs [35, 37]. Assessing the precise contribution of TLRs and C-type lectins in our model will await availability of reagents appropriate for use with bovine cells. Importantly, as far as CBPP is concerned, lipoproteins rather than LPS are in the top list of putative pro-inflammatory Mmm molecules . Interestingly, IL-10 has also been shown to dampen the pro-inflammatory activity of lipoproteins [39, 40].
Galactan EPS from Mmm increased the expression of CD40 and CD80 co-stimulatory molecules on the surface of macrophages. In addition, galactan-specific recall proliferation of CD4+ T lymphocytes and IFN-γ responses were detected among lymphocytes draining the lungs of CBPP-infected cattle. However, cell mediated immune responses against galactan differed from recall responses triggered by whole inactivated Mmm in several ways. First, only CD4+ T lymphocytes proliferated in response to galactan whereas both CD4+ and CD4− T lymphocytes (most likely B lymphocytes as reported previously ) responded to Mmm. Second, both proliferation and IFN-γ recall responses induced by galactan were significantly lower (p < 0.05) than those triggered by Mmm. Third, a high amount of galactan was needed to match Mmm-induced proliferation of CD4+ T lymphocytes but IFN-γ levels remained substantially lower. Thus, the galactan-specific CD4+ T lymphocytes elicited in these animals are relatively poor producers of the Th1 cytokine when compared to their Mmm-specific homologues. A more complete cytokine profiling, including Th2, Th17 and Th22 cytokines, may be required in order to better characterize these responses.
In summary, we have shown here that galactan EPS, the free soluble form of Mmm polysaccharide, possesses anti-inflammatory properties and induces the production of IL-10 by macrophages. This result provides a likely explanation for the progressive increase in IL-10 detected in the plasma of cattle undergoing experimental CBPP . Moreover, large amount of galactan are found in the blood of animals undergoing acute CBPP  which is also consistent with higher levels of plasma IL-10 detected in these animals when compared to animals with chronic CBPP . In addition to multiple inhibitory effects on innate immunity (e.g., inhibition of pro-inflammatory cytokine release by macrophages [41, 42], and reduction of macrophage microbicidal activity ), IL-10 may also attenuate adaptative immunity by down-regulating the expression of IL-2 receptor on bovine T lymphocytes . Thus, galactan may potentially also depress T cell responses directed at Mmm proteins. Interestingly, lower Mmm-induced recall activation of CD4+ T lymphocytes was detected in draining lymph nodes of animals chronically infected (i.e., presence of Mmm -containing sequestra in the lungs) in comparison to animals showing complete recovery . Also, we have recently reported the absence of measurable T-cell responses in cattle one month after immunization with the attenuated T1/44 vaccine strain of Mmm . The T1/44 strain also produces the EPS form of galactan  which may therefore potentially contribute to its poor T-cell immunogenicity.
All together our results suggest that free Mmm galactan, or EPS, is not involved in the inflammatory reaction which is the hallmark of acute CBPP. Thus, more work is needed to evaluate pro-inflammatory properties of other components of the Mmm membrane, including the CPS form of galactan and lipoproteins, as well as the Mmm secretome as a whole. In addition, our results suggest that EPS may dampen the host innate and possibly also acquired cell-mediated immune responses through the production of immunosuppressive IL-10. The role of other well-known mediators of innate immunity such as chemokines, but also other immunocompetent cells such as NK cells and dendritic cells deserves in-depth investigation.
The authors declare that they have no competing interests.
Conceived and designed the experiments: FT, PT, VR, LMS. Performed the experiments: CP, PT. Analyzed the data: PT, FT, LMS, VR, CP. Contributed reagents: CB. Wrote the paper: PT, CP, VR. All authors read and approved the final manuscript.
Chlotilde Bertin was a recipient of a PhD grant awarded jointly by ANSES (Agence Nationale de Sécurite Sanitaire, France) and CIRAD.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- World Organization for Animal Health (2015). http://oie.int/en/animal-health-in-the-world/oie-listed-diseases-2015/. Accessed 4 Sept 2015
- Provost A, Perreau P, Bréard A (1987) Contagious bovine pleuropneumonia. Rev Sci Tech 6:625–679Google Scholar
- Jungi TW, Krampe M, Sileghem M, Griot C, Nicolet J (1996) Differential and strain-specific triggering of bovine alveolar macrophage effector functions by mycoplasmas. Microb Pathog 2:487–498View ArticleGoogle Scholar
- Sacchini F, Luciani M, Salini R, Scacchia M, Pini A, Lelli R, Naessens J, Poole J, Jores J (2012) Plasma levels of TNF-α, IFN-γ, IL-4 and IL-10 during a course of experimental contagious bovine pleuropneumonia. BMC Vet Res 8:44PubMed CentralView ArticlePubMedGoogle Scholar
- Westberg J, Persson A, Holmberg A, Goesmann A, Lundeberg J, Johansson KE, Pettersson B, Uhlen M (2004) The genome sequence of Mycoplasma mycoides subsp. mycoides SC type strain PG1T, the causative agent of contagious bovine pleuropneumonia (CBPP). Genome Res 14:221–227PubMed CentralView ArticlePubMedGoogle Scholar
- Wise KS, Calcutt MJ, Foecking MF, Madupu R, DeBoy RT, Roske K, Hvinden ML, Martin TR, Durkin AS, Glass JI, Methe BA (2012) Complete genome sequences of Mycoplasma leachii strain PG50T and the pathogenic Mycoplasma mycoides subsp. mycoides small colony biotype strain Gladysdale. J Bacteriol 194:4448–4449PubMed CentralView ArticlePubMedGoogle Scholar
- Pilo P, Vilei EM, Peterhans E, Bonvin-Klotz L, Stoffel MH, Dobbelaere D, Frey J (2005) A metabolic enzyme as a primary virulence factor of Mycoplasma mycoides subsp. mycoides small colony. J Bacteriol 187:6824–6831PubMed CentralView ArticlePubMedGoogle Scholar
- Kannan TR, Baseman JB (2006) ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A 103:6724–6729PubMed CentralView ArticlePubMedGoogle Scholar
- Plackett P, Buttery SH (1964) A galactofuranose disaccharide from the galactan of Mycoplasma mycoides. Biochem J 90:201–205PubMed CentralView ArticlePubMedGoogle Scholar
- Bertin C, Pau-Roblot C, Courtois J, Manso-Silván L, Thiaucourt F, Tardy F, Le Grand D, Poumarat F, Gaurivaud P (2013) Characterization of free exopolysaccharides secreted by Mycoplasma mycoides subsp. mycoides. PLoS One 8:e68373PubMed CentralView ArticlePubMedGoogle Scholar
- Andrés E, Martínez N, Planas A (2011) Expression and characterization of a Mycoplasma genitalium glycosyltransferase in membrane glycolipid biosynthesis: potential target against mycoplasma infections. J Biol Chem 286:35367–35379PubMed CentralView ArticlePubMedGoogle Scholar
- Turner AW (1962) Circulating M. mycoides antigen as a cause of loss agglutination and complement fixation reactivity during acute pleuropneumonia. Aust Vet J 38:401Google Scholar
- Buttery SH, Lloyd LC, Titchen DA (1976) Acute respiratory, circulatory and pathological changes in the calf after intravenous injections of the galactan from Mycoplasma mycoides subsp. mycoides. J Med Microbiol 9:379–391View ArticlePubMedGoogle Scholar
- Lloyd LC, Buttery SH, Hudson JR (1971) The effect of the galactan and other antigens of Mycoplasma mycoides var. mycoides on experimental infection with that organism in cattle. J Med Microbiol 4:425–439View ArticlePubMedGoogle Scholar
- Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376View ArticlePubMedGoogle Scholar
- Vilcek J (1994) The cytokines: an overview. In: Angus W, Thomson MTL (eds) The cytokine handbook, 4th edn. Academic Press, San DiegoGoogle Scholar
- Soell M, Diab M, Haan-Archipoff G, Beretz A, Herbelin C, Poutrel B, Klein JP (1995) Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect Immun 63:1380–1386PubMed CentralPubMedGoogle Scholar
- Wang Q, McLoughlin RM, Cobb BA, Charrel-Dennis M, Zaleski KJ, Golenbock D, Tzianabos AO, Kasper DL (2006) A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med 203:2853–2863PubMed CentralView ArticlePubMedGoogle Scholar
- Graveline R, Segura M, Radzioch D, Gottschalk M (2007) TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness. Int Immunol 19:375–389View ArticlePubMedGoogle Scholar
- Yang FL, Yang YL, Liao PC, Chou JC, Tsai KC, Yang AS, Sheu F, Lin TL, Hsieh PF, Wang JT, Hua KF, Wu SH (2011) Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through Toll-like receptor 4. J Biol Chem 286:21041–21051PubMed CentralView ArticlePubMedGoogle Scholar
- Zughaier SM (2011) Neisseria meningitidis capsular polysaccharides induce inflammatory responses via TLR2 and TLR4-MD-2. J Leukoc Biol 9:469–480View ArticleGoogle Scholar
- Brubaker JO, Li Q, Tzianabos AO, Kasper DL, Finberg RW (1999) Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro. J Immunol 162:2235–2242PubMedGoogle Scholar
- Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2:116–126View ArticlePubMedGoogle Scholar
- Totté P, Rodrigues V, Yaya A, Hamadou B, Cisse O, Diallo M, Niang M, Thiaucourt F, Dedieu L (2008) Analysis of cellular responses to Mycoplasma mycoides subsp. mycoides small colony biotype associated with control of contagious bovine pleuropneumonia. Vet Res 39:8View ArticlePubMedGoogle Scholar
- Dedieu L, Chapey E, Balcer-Rodrigues V (2005) Mycoplasma mycoides subsp. mycoides biotype small colony-secreted components induce apoptotic cell death in bovine leucocytes. Scand J Immunol 62:528–538View ArticlePubMedGoogle Scholar
- Dedieu L, Balcer-Rodrigues V, Cisse O, Diallo M, Niang M (2006) Characterisation of the lymph node immune response following Mycoplasma mycoides subsp. mycoides SC infection in cattle. Vet Res 37:579–591View ArticlePubMedGoogle Scholar
- Hope JC, Kwong LS, Entrican G, Wattegedera S, Vordermeier HM, Sopp P, Howard CJ (2002) Development of detection methods for ruminant interleukin (IL)-12. J Immunol Methods 266:117–126View ArticlePubMedGoogle Scholar
- Saarland University WWW Server. http://www.ccb.uni-saarland.de/?page_id=812. Accessed 26 Aug 2015
- Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY (2004) TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A 101:3029–3034PubMed CentralView ArticlePubMedGoogle Scholar
- Almeida RA, Wannemuehler MJ, Rosenbusch RF (1992) Interaction of Mycoplasma dispar with bovine alveolar macrophages. Infect Immun 60:2914–2919PubMed CentralPubMedGoogle Scholar
- Wu MH, Pan TM, Wu YJ, Chang SJ, Chang MS, Hu CY (2010) Exopolysaccharide activities from probiotic bifidobacterium: immunomodulatory effects (on J774A.1 macrophages) and antimicrobial properties. Int J Food Microbiol 144:104–110View ArticlePubMedGoogle Scholar
- Liu L, Li YH, Niu YB, Sun Y, Guo ZJ, Li Q, Li C, Feng J, Cao SS, Mei QB (2010) An apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS/TLR4/NF-κB pathway in a mouse model of colitis-associated colon cancer. Carcinogenesis 31:1822–1832View ArticlePubMedGoogle Scholar
- Li X, Jiang J, Shi S, Bligh SW, Li Y, Jiang Y, Huang D, Ke Y, Wang S (2014) A RG-II type polysaccharide purified from Aconitum coreanum alleviates lipopolysaccharide-induced inflammation by inhibiting the NF-κB signal pathway. PLoS One 13:e99697View ArticleGoogle Scholar
- Diao Y, Xin Y, Zhou Y, Li N, Pan X, Qi S, Qi Z, Xu Y, Luo L, Wan H, Lan L, Yin Z (2014) Extracellular polysaccharide from Bacillus sp. strain LBP32 prevents LPS-induced inflammation in RAW 264.7 macrophages by inhibiting NF-κB and MAPKs activation and ROS production. Int Immunopharmacol 18:12–19View ArticlePubMedGoogle Scholar
- Geurtsen J, Chedammi S, Mesters J, Cot M, Driessen NN, Sambou T, Kakutani R, Ummels R, Maaskant J, Takata H, Baba O, Terashima T, Bovin N, Vandenbroucke-Grauls CM, Nigou J, Puzo G, Lemassu A, Daffé M, Appelmelk BJ (2009) Identification of mycobacterial alpha-glucan as a novel ligand for DC-SIGN: involvement of mycobacterial capsular polysaccharides in host immune modulation. J Immunol 183:5221–5231View ArticlePubMedGoogle Scholar
- Williams L, Bradley L, Smith A, Foxwell B (2004) Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages. J Immunol 172:567–576View ArticlePubMedGoogle Scholar
- Gringhuis SI, den Dunnen J, Litjens M, van het Hof B, van Kooyk Y, Geijtenbeek TB (2007) C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26:605–616View ArticlePubMedGoogle Scholar
- Chambaud I, Wróblewski H, Blanchard A (1999) Interactions between mycoplasma lipoproteins and the host immune system. Trends Microbiol 12:493–499View ArticleGoogle Scholar
- Murthy PK, Dennis VA, Lasater BL, Philipp MT (2000) Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins. Infect Immun 68:6663–6669PubMed CentralView ArticlePubMedGoogle Scholar
- Gautam A, Dixit S, Embers M, Gautam R, Philipp MT, Singh SR, Morici L, Dennis VA (2012) Different patterns of expression and of IL-10 modulation of inflammatory mediators from macrophages of Lyme disease-resistant and -susceptible mice. PLoS One 7:e43860PubMed CentralView ArticlePubMedGoogle Scholar
- Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815–3822PubMedGoogle Scholar
- Brown JP, Zachary JF, Teuscher C, Weis JJ, Wooten RM (1999) Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun 67:5142–5150PubMed CentralPubMedGoogle Scholar
- Silva JS, Morrissey PJ, Grabstein KH, Mohler KM, Anderson D, Reed SG (1992) Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 175:169–174View ArticlePubMedGoogle Scholar
- Chitko-McKown CG, Ruef BJ, Rice-Ficht AC, Brown WC (1995) Interleukin-10 downregulates proliferation and expression of interleukin-2 receptor p55 chain and interferon-gamma, but not interleukin-2 or interleukin-4, by parasite-specific helper T cell clones obtained from cattle chronically infected with Babesia bovis or Fasciola hepatica. J Interferon Cytokine Res 15:915–922View ArticlePubMedGoogle Scholar
- Totte P, Yaya A, Sery A, Wesonga H, Wade A, Naessens J, Niang M, Thiaucourt T (2013) Characterization of anamnestic T-cell responses induced by conventional vaccines against contagious bovine pleuropneumonia. PLoS One 8:e57509PubMed CentralView ArticlePubMedGoogle Scholar
- Gaurivaud P, Persson A, Grand DL, Westberg J, Solsona M, Johansson KE, Poumarat F (2004) Variability of a glucose phosphotransferase system permease in Mycoplasma mycoides subsp. mycoides Small Colony. Microbiology 150:4009–4022View ArticlePubMedGoogle Scholar